11-63629362-T-TC
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_015459.5(ATL3):c.1582_1583insG(p.Asp528GlyfsTer11) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000752 in 1,461,886 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000075 ( 0 hom. )
Consequence
ATL3
NM_015459.5 frameshift
NM_015459.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.39
Genes affected
ATL3 (HGNC:24526): (atlastin GTPase 3) This gene encodes a member of a family of dynamin-like, integral membrane GTPases. The encoded protein is required for the proper formation of the network of interconnected tubules of the endoplasmic reticulum. Mutations in this gene may be associated with hereditary sensory neuropathy type IF. Alternatively spliced transcript variants that encode distinct isoforms have been described. [provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 11 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATL3 | NM_015459.5 | c.1582_1583insG | p.Asp528GlyfsTer11 | frameshift_variant | 13/13 | ENST00000398868.8 | NP_056274.3 | |
ATL3 | NM_001290048.2 | c.1528_1529insG | p.Asp510GlyfsTer11 | frameshift_variant | 13/13 | NP_001276977.1 | ||
ATL3 | XM_006718493.2 | c.1525_1526insG | p.Asp509GlyfsTer11 | frameshift_variant | 12/12 | XP_006718556.1 | ||
ATL3 | XM_047426725.1 | c.1738_1739insG | p.Asp580GlyfsTer11 | frameshift_variant | 14/14 | XP_047282681.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATL3 | ENST00000398868.8 | c.1582_1583insG | p.Asp528GlyfsTer11 | frameshift_variant | 13/13 | 1 | NM_015459.5 | ENSP00000381844 | ||
ATL3 | ENST00000538786.1 | c.1528_1529insG | p.Asp510GlyfsTer11 | frameshift_variant | 13/13 | 2 | ENSP00000437593 | P1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249572Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135406
GnomAD3 exomes
AF:
AC:
5
AN:
249572
Hom.:
AF XY:
AC XY:
3
AN XY:
135406
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461886Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 727246
GnomAD4 exome
AF:
AC:
11
AN:
1461886
Hom.:
Cov.:
30
AF XY:
AC XY:
4
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 28, 2023 | Variant summary: ATL3 c.1582dupG (p.Asp528GlyfsX11) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, however the molecular mechanism of disease attributed to ATL3 is gain-of-function. The variant allele was found at a frequency of 2e-05 in 249572 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1582dupG in individuals affected with Neuropathy, Hereditary Sensory, Type 1F and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at